Welcome to the Office of Clinical Research

News-At-A-Glance (Highlighting Clinical Researchers at Penn)

The CAR-T technique involves removing a patient's T cells and inserting new genetic material that enables the T cells to attack and kill cancer cells. The modified cells are then infused back into the patient's body following chemotherapy to fight the remaining tumors. The new approach is the result of pioneering research by Drs. Grupp, June and their colleagues and has the potential to help patients with other types of cancer, including brain, lung, ovary, pancreas, prostate and breast cancers. Listen

Read more about Dr. Stephan Grupp, MD, PhD here and Emily Whitehead’s story here


Announcements:

New Question in Penn Profiler - Impacts to GCP Training

A new question has been added to Penn Profiler which is intended to capture, and assign training, to faculty and staff who are involved in the conduct of a clinical trial. The question asks, "Are you involved in the conduct, oversight or management of a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of those interventions on health-related biomedical or behavioral outcomes? This includes both interventional clinical trials and behavioral health interventional studies"

For those who answer affirmatively, Good Clinical Practice (GCP) training will be signed via Knowledge Link (KL) in accordance with the Standard Operating Procedures (SOP) unless training has already been completed. GCP training is required, and must be refreshed, every 3 years for those involved in the conduct of a clinical trial.

Detailed information can be found under “Training Required for Clinical Research


Clinical Trials Radio Blog
"Beating Leukemia with Groundbreaking CAR-T Cell Therapy"

Background: The CAR-T technique involves removing a patient's T cells and inserting new genetic material that enables the T cells to attack and kill cancer cells. The modified cells are then infused back into the patient's body following chemotherapy to fight the remaining tumors. The new approach is the result of pioneering research by Drs. Grupp, June and their colleagues and has the potential to help patients with other types of cancer, including brain, lung, ovary, pancreas, prostate and breast cancers.

Read more about Dr. Stephan Grupp, MD, PhD here and Emily Whitehead’s story here
 
Questions? Please contact the Office of Clinical Research (OCR) at psom-ocr@pobox.upenn.edu or 215-662-4484.  Please feel free to forward this information.


2018 C.A.R.E Awards

Clinical Research Annual Recognition of Excellence Awards

The Clinical Research Coordinator Annual Recognition of Excellence (CARE) award is an annual recognition event hosted by the Penn Society of Clinical Research Coordination and Management (SCRCM) and the Office of Clinical Research (OCR). This event is to celebrate our clinical research staff at Penn and honor members of our research community who best exemplifies excellence in the knowledge, skills and values of the clinical research profession.

Join Us at the 2018 C.A.R.E Awards!

When:   Thursday, June 14th 2018    11:45 am to 2:00 pm

Where:  Biomedical Research Building (BRB) Auditorium


Links: 

Archived Announcements